💻 Technology
Live
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
It will be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.
Wired — 9 June 2026
Text:
8
0
0
It will be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.
This report comes from Wired. The story centres on Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from Wired and related outlets covering this beat.
Sources
💻 Technology
Cash App made a magic wand for contactless payments
💻 Technology
Meta is reportedly developing an AI pendant
💻 Technology
Hackers hijacked Instagram accounts by tricking Meta AI support chatbot into granting access
💻 Technology
Coders are refusing to work without AI — and that could come back to bite them
💻 Technology
‘Backrooms’ $118M WW Bonanza; ‘Obsession’ Obsessed With $148M WW; ‘Michael’ Nearing $900M WW – Global Box Office Update
💻 Technology
Asus gives the ROX Xbox Ally the OLED screen it deserves
